The Clorox Company AI Price Prediction

With EPS at 3.70 and a PE ratio of 27.58, the stock trades at a premium valuation relative to what appears to be modest earnings power. That combination suggests the market is pricing in stability or growth that is not clearly supported by the limited fundamentals provided. Profitability is positive, but not strong enough to offset valuation risk if growth disappoints.

• EPS of 3.70 indicates the company is profitable, but not generating outsized earnings relative to its current share price.
• A PE ratio of 27.58 is elevated for a mature consumer staples company, implying expectations of resilience or growth that may be difficult to achieve in a slower-demand environment.
• Given the premium multiple and no evidence here of strong revenue or margin acceleration, the risk/reward skews negatively if fundamentals soften.

The stock trades at $101.90, modestly up 1.2% in the last month but still far below its 200-day moving average of $146.01, indicating a sustained downtrend. An RSI of 38.69 shows the stock is weak but not deeply oversold, suggesting selling pressure has eased but not reversed. Overall, technicals point to a damaged chart with only tentative stabilization.

• Price at $101.90 versus a 200-day moving average of $146.01 signals a pronounced longer-term downtrend and that the stock remains under its major resistance zone.
• The 1.2% gain over the last month is modest and does not meaningfully change the broader negative technical structure.
• RSI at 38.69 is below neutral (50) but above oversold (30), reflecting weak momentum without a clear capitulation or strong reversal signal.

Clorox’s stock appears fundamentally expensive relative to its earnings power and is technically in a clear downtrend, despite a small recent bounce. Alternative data show steady but unspectacular engagement and a slight pullback in hiring, which do not strongly support a near-term growth acceleration. Taken together, the setup leans bearish, with valuation and technicals outweighing only modestly positive alternative data.

• Premium valuation and weak technical profile (price well below 200-day moving average, sub-50 RSI) dominate the risk/reward outlook.
• Alternative data are generally stable rather than strongly expansionary, limiting the case for a rapid fundamental or sentiment-driven re-rating.